This study on a patient with prior breast cancer investigated the cause-effect relations between immune system activation, fatigue and mood under real-life conditions. The 60-year old woman (primary diagnosis 5 years ago, relapse one year ago, currently no signs of recurrence) collected her entire urine for 31 days in 12 hour intervals for the determination of immune activation marker neopterin and creatinine concentrations by HPLC. This study used only the daytime urinary neopterin concentrations (from approx. 8 a.m. to 8 p.m.) and cross-correlated them with daily data from mood (3-Skalen-EWL) and fatigue (VAS) questionnaires which the patient filled in for 31 days. Serial dependencies were controlled for by applying moving average smoothing. When averaged over the whole observation period, daily fatigue, daily mood and daily urinary neopterin (average 173 µmol per mol creatinine) were within normal limits. Cross-correlational analyses revealed that increases in urinary neopterin significantly preceded increases in fatigue by 24 hours (lag 1: r = +0.424; p <0.05). The opposite direction of effects, however, existed between mood and neopterin, i.e., decreases in mood preceded increases in neopterin by 96 hours (lag 4: r = −0.697; p <0.05). The results in this patient suggest a disturbed stress system activity where negative emotions are associated with increases instead of decreases in the degree of cellular immune activation and where cellular immune activation may trigger central nervous system symptoms such as fatigue. Despite some restrictions in data quality this study shows the feasibility of gathering evidence on naturally occurring psychoimmunological cause-effect relations based on extensive serial data collection and time series analysis.
Introduction
Psycho-oncological research on cancer-related depression and neuropsychiatric symptoms usually focuses on the psychosocial aspects of cancer and its treatment such as coping strategies, social support, and problem solving (1) . However, increasing evidence has suggested that the release of pro-inflammatory cytokines during inflammatory processes may play an important role in cancer-related psychiatric disease (2) .
Experimental studies showed that depression and fatigue, as well as an array of other psychological and behavioural disturbances ("sickness-behavior"), can be triggered by parenteral administration of recombinant pro-inflammatory cytokines, e.g., interferon (IFN), interleukins IL-6, IL-12, IL-2 and IL-1β, and tumor necrosis factor-α (TNF-α), to promote anticancer immune response (3) (4) (5) . Furthermore, a naturalistic comparison study demonstrated that cancer patients with depression have higher plasma levels of IL-6 than those without depression and healthy controls (6) . Likewise, a quantitative review on 18 group studies dealing with fatigue and inflammatory markers in cancer patients not receiving immunotherapy revealed that cancer-related fatigue (CaRF) is reliably correlated with increased IL-6, IL-1 receptor antagonist (IL-1ra) and neopterin levels (7) . Furthermore, relative to nonfatigued controls, monocytes of fatigued patients with prior breast cancer showed enhanced LPS-induced IL-6 and IL-1β production following a public speaking stressor (8) .
An important limitation of studies, where cytokine levels were experimentally altered through application of recombinant molecules, is that serum levels of parenterally applied cytokines by far exceed serum cytokine levels that can usually be seen in patients suffering from chronic inflammation (9) . On the other hand, naturalistic comparison and correlation studies have the disadvantage that they cannot address the critical issue of causal direction between increases in cytokines and psychological changes. Such studies leave open whether elevated cytokine levels are the reason for mood changes or whether -vice versamood changes are responsible for triggering immunological activity (10) . This is a clinically relevant gap in our knowledge, because development of new treatment strategies for neuropsychiatric syndromes in cancer patients depends on the basic understanding of their functional characteristics under real-life conditions.
The goal of this single-case study on a patient with prior breast cancer was to gather first evidence on the naturally occurring cause-effect relations between immune system activity, fatigue and mood taking possible bidirectional effects into consideration (11) . Regarding methodological aspects, we followed an alternative path to conventional study designs in that extensive time series were gathered under real-life conditions to statistically analyze their dynamic interdependencies applying time series analysis. The "integrative" design of this study (12, 13) demanded a great deal from the patient, as she had to collect her entire urine daily for a period of one month, fill in daily questionnaires, and meet weekly with the interviewer. In order to be able to fulfill the design requirements, it was important that the patient neither suffered from medical nor from psychiatric disease, which could have compromised her compliance during the following month. It can be assumed that common decreases in the patient's mood and increases in her fatigue may just as well as major depression and CaRF be associated with immune alterations, since distress in cancer extends along a continuum ranging from normal psychological alterations to psychopathological manifestations (14) . Furthermore, to interfere as little as possible with the patient's normal routine, daily urine was collected by the patient herself and urinary neopterin concentrations were determined as a non-invasive way to monitor pro-inflammatory cytokine activity. Proinflammatory cytokines belong to the T helper type 1 (Th1) subtype family which involve IFN-γ to activate, e.g., neopterin production in macrophages (15) . Thus, given that urinary neopterin is highly correlated with serum/plasma neopterin (16) , urinary neopterin levels might directly reflect the biochemical changes that were induced by pro-inflammatory cytokines (17) .
Methods

Study design
Before onset of the study, the patient was examined medically by an experienced senior gynaecologist (clinical examination, blood chemistry) and psychologically by an experienced senior psychiatrist (interview). In line with a recent study of Bower and colleagues (18) , this study had the following inclusion criteria: 1) early resectable breast cancer stage at diagnosis (stage 0, I or II); 2) completion of local and/or systemic adjuvant cancer therapy; 3) initial breast cancer diagnosis was made between 3 and 7 years earlier; 4) clinically free from evidence of metastatic or recurrent lesions; 5) age 18 years or older; 6) postmenopausal; 7) can read and write German; 8) can provide informed consent. The exclusion criteria were as follows: 1) history of immunologically or endocrinologically related diseases or diseases that could affect the endocrine as well as the immune system; 2) history of psychiatric hospitalization or severe psychological distress in the last 6 months; 3) regular use of medication which could affect the biochemical or psychological parameters to be investigated in the proposed project (e.g. immunosuppressants, antidepressants); 4) excessive alcohol consumption (more than 15 alcoholic beverages per week).
This study is part of a larger project on patients with prior breast cancer, in which the impact of emotionally meaningful everyday incidents on the dynamic course of various endocrinological and immunological parameter levels is investigated. For this purpose, the patient of this study collected her entire urine for a period of 32 days (from and from 8 a.m. to 8 p.m.) resulting in 63 consecutive urinary neopterin measurements. Urinary specimens were protected from sedimentation and oxidation by adding both EDTA and sodium-hydrogensulfite. Each evening at approx. 8 p.m. and each morning at approx. 8 a.m., the patient noted the total volume of urine, aliquoted samples into plastic tubes and froze them at −20°C. Once per week, when the patient had an inter-view in the clinic, she brought the frozen urine samples with her using a cold box for transportation. The samples were kept frozen at −70°C until further analysis. Time series of psychological factors were based on questionnaires which the patient had to fill in in 12-hour intervals, i.e., each morning (for the interval from 8 p.m. to 8 a.m.) and each evening (for the interval from 8 a.m. to 8 p.m.) of the study period. However, regarding the fatigue time series, the patient accidentally received only questionnaires to fill in that regarded the 31 daytime fractions (intervals from 8 a.m. to 8 p.m.) of the study period. Consequently, the current study used only those 31 daily urinary neopterin and mood measurements for time series analysis that corresponded to the 31 daily fatigue measurements.
The study was approved by the internal review board of the Hannover Medical School (Medizinische Hochschule Hannover, MHH). The patient gave informed consent to her participation and to the publication of data.
Description of the patient
The patient is 60 years-old, married for 33 years (husband diagnosed with colon cancer in February 1999, since then no recurrence) and childless. About five years prior to the onset of the study (October 1999), the patient was diagnosed with a ductal mamma carcinoma at her left breast (pT1c, N0, M0, G2, Her2-/neu receptor positive). She then underwent breastconserving surgery and received radiotherapy. From December 1999 (end of radiotherapy) until midyear 2001 the patient had been suffering from CaRF and symptoms of depression. In December 2003 a recurrence was diagnosed in her left breast, which was consequently removed. Further recurrence suspicion in October 2004 proved wrong. Adjuvant therapy consisted of tamoxifen (anti-estrogen) up to the recurrence diagnosis and then anastrozole (Arimidex), an aromatase inhibitor. Since November 1999 she has been seeing a psychoanalyst (approx. 230 hours, "I felt the strong urge to get help and was convinced that I would receive it by means of psychoanalysis").
Mood measurement
The 3-Skalen Version der Eigenschaftswörterliste (3-Skalen-EWL; 'list of adjectives') (19) is a paperpencil test to measure the proband's emotional state (i.e., mood, mental energy levels, irritation) using 28 adjectives each of which is assessed on a four-point scale (1 = not at all, 2 = a little, 3 = quite, 4 = very). The factor mood is made up of four positive (i.e., glad, good mood, happy, joyful) and four negative (i.e., depressed, sad, gloomy, worried) adjectives and can range from −12 to +12. The use of the 3-scale-EWL in longitudinal designs is recommended. The proband needs about five minutes to complete the test.
Fatigue measurement
Fatigue intensity was continuously scored using a visual analogue scale (VAS). In this scale the patient is asked to answer the German equivalent of the question 'considering the last 12 hours how would you assess your fatigue?' and place a vertical mark on a 10-cm long horizontal line. The anchoring points of this scale are the German equivalents for 'not at all' and 'strong'.
Laboratory analyses 12-hour urinary neopterin and creatinine concentrations were determined using high pressure liquid chromatography (ProStar series model 210 solvent delivery module and model 400 autosampling devise, flurichrom fluorescence detector and UV100 spectrophotometer, all from Varian Associates, Palo Alto, CA) on reversed phase (20) . All 63 urine aliquots were measured in one single run within three months following collection. Urinary neopterin concentrations were expressed per molar concentration of creatinine to compensate for variations in urine density. To check for possible measurement errors, we analyzed urinary neopterin and creatinine concentrations in three independent runs, each time applying a new aliquot. The resulting three urinary neopterin per creatinine (µmol/mol) time series were averaged.
Time series analysis
Cross-correlational analysis (SPSS-Trends™ 14.0) was used in order to identify direction of effects and temporal delays between the time series of daily urinary neopterin concentrations, fatigue and mood, each consisting of 31 consecutive measurements. In crosscorrelational analysis two time series are correlated both at zero lag (i.e. contemporaneous correlation) and at higher lags (up to ± 7) in order to determine whether one variable significantly precedes and hence predicts the other. For pair wise computation, SPSS-Trends™ 14.0 includes automatic alpha adjustment. Cross-correlations were considered statistically significant when they met the p <0.05 criterion. Because of serial dependencies which are due to periodically occurring phenomena (e.g. regular medication intake) and trends, unadjusted cross-correlational analysis may lead to false-positive or false-negative correlations. Therefore, in case of significant autocorrelations which are indicative of strong serial regularities in the time series, adjusted cross-correlational analysis using only time series residuals not significantly different from 0 (i.e., white noise) was implemented (21) .
Residuals were generated by centered moving average smoothing (22, 23) . Smoothing time series is a non-parametric technique which can be applied to very short-term time series (24) . Moving average smoothing highlights the underlying trend in a time series and strips away random fluctuations. It recalculates each value of the original time series by smoothing it as the nonweighted average of the previous observations. In this study, an even span of 6 values was applied for computing averages which results in a centered moving average by averaging each pair of uncentered means. As 6 values are not available at the time series ends, a minimum of 1 value was used at the endpoints of the original time series in order not to lose values at the endpoints of the new series. If a time series had missing values, we substituted through linear interpolation before smoothing the series. Residuals were gathered by subtracting the smoothed series from the original series (22, 23).
Results
Figure 1A-C shows the time series of daily urinary neopterin concentrations, daily fatigue and daily mood levels each covering a period of 31 12-hour units. There was one missing value (Day 11) in the daily fatigue time series (Fig. 1A) which was substituted via linear interpolation before smoothing the series. Mean daily fatigue over 30 measurements was 0.09 ± 0.19cm ranging from 0 to 0.65. 21 of the 30 daily fatigue values were zeros (i.e., 70%), which skewed the data distribution (skewness = 1.97 ± 0.42, kurtosis = 2.82 ± 0.82). Mean daily mood over 31 measurements was +9.52 ± 2.01 ranging from +2 to +12. The patient experienced her lowest mood level on Day 17 of the study (December 24 th ) (Fig. 1B) . The urinary neopterin and creatinine concentrations proved to be stable when repeatedly measured. Mean daily urinary neopterin was 173 ± 93 µmol per mol creatinine ranging from 104 to 637. On Day 21 (December 28 th ), a strong increase in daily urinary neopterin up to 637 µmol/mol creatinine occurred (Fig. 1C) . The patient did not report any signs of an infectious episode during the whole observation period, nor did the interviewer realize any signs of infection in the patient during their weekly meetings.
To determine the dynamic interdependencies between daily urinary neopterin concentrations, daily fatigue and daily mood, we applied adjusted cross-correlational analysis. To achieve stationarity and normalize skewed distributions, the time series of urinary neopterin concentrations, mood and fatigue were transformed by natural logarithm. Both time series of urinary neopterin concentrations and mood did not need to be smoothed because autocorrelation functions showed no significant deviations from 0. The logarithmized fatigue time series was smoothed because of a significant lag1 autocorrelation (lag1: r = +0.386; p <0.05). The cross-correlogram on the cross-correlations between daily urinary neopterin concentrations and daily mood in Figure 2A shows that decreases in the patient's daily mood significantly preceded increases in her daily urinary neopterin levels by 96 hours (lag4: r = −0.697; p <0.05). Cross-correlational analysis between daily urinary neopterin concentrations and daily fatigue revealed that increases in daily urinary neopterin concentrations preceded increases in daily fatigue levels by 24 hours (lag1: r = +0.424; p <0.05) (Fig. 2B ). There was a strong tendency for daily mood increases to precede daily fatigue decreases by 24 hours (lag1: r = −0.361; n.s.) and 120 hours (lag5: r = −0.375; n.s.) (Fig. 2C) .
Discussion
Most studies that as yet have investigated the relationship between pro-inflammatory cytokine activity and psychological factors in cancer patients cannot make inferences about naturally occurring causal relations among the variables. The current integrative single-case study sought to take a closer look at the dynamic relationship between neopterin, as an indicator of pro-inflammatory response, and mood as well as fatigue in a 60-year-old patient with prior breast cancer. For this purpose, the patient collected her entire daily urine for a period of 31 days for the determination of neopterin and filled out daily questionnaires on mood and fatigue.
The patient's average urinary neopterin concentration over the whole observation period lies within the normal range of urinary neopterin concentrations of the corresponding age group (for 56-to 65-year-old women, mean ± S.D.: 156 ± 35; 97.5 th percentile: 249 µmol/mol creatinine; see Ref. 17) . Moreover, the patient's mean levels in self-reported fatigue and mood were also not pathologically altered (19, 25) . Regarding the mean values of urinary neopterin concentration, fatigue and mood, the findings on this patient correspond to recent evidence from a cross-sectional study that patients with prior breast cancer who do not suffer from CaRF and other forms of psychiatric disease do also not have increased IL-1ra, soluble tumor necrosis factor receptor type II (sTNF-RII), or neopterin levels (18) .
In this study, adjusted cross-correlational analysis was applied in order to investigate bidirectional effects between neopterin, fatigue and mood. Our analyses revealed that urinary neopterin concentrations were differentially related to mood and fatigue, both in terms of directions of effect and temporal delays. Decreases in the patient's mood during the study peri-A B C Figure 2 . Cross-correlational functions between daily mood and daily urinary neopterin (A), daily urinary neopterin and daily fatigue (B) and daily mood and daily fatigue (C). Plots show cross-correlation coefficients as well as upper and lower limits of the 95% confidence intervals. od significantly preceded increases in urinary neopterin concentrations by 96 hours. Increases in fatigue, on the other hand, significantly followed increases in urinary neopterin levels by 24 hours.
The finding that under natural conditions increases in neopterin levels preceded increases in fatigue and not vice versa is in accordance with experimental studies on cancer patients where fatigue can be parenterally induced by recombinant pro-inflammatory cytokines (26, 27) . Our findings also agree with results from studies on healthy individuals that applied low doses of cytokines or cytokine inducers in order to mirror cytokine increases in serum typically observed after infectious challenge. Späth-Schwalbe and colleagues, for example, investigated the acute effects of a low IL-6 dose (0.5 mg/kg body weight) in a healthy group of males and found that serum concentrations of 75-100 pg/ml were significantly associated with increases in fatigue and the feeling of being more inactive and less capable of concentrating than after placebo (28) .
The temporal delay of 24 hours with which neopterin increases preceded fatigue increases in our patient resembles the delays observed in anticancer immunotherapy studies. In cancer patients administered IFN-α therapy, fatigue usually occurs during the first days of treatment and develops more insidiously when low doses are applied (29, 30) . In comparison, the healthy subjects in the Späth-Schwalbe study (28) reported fatigue approx. 3 hours after a single low dose subcutaneous injection of IL-6. Regarding the patient of the current study, it cannot be ruled out that neopterin-related fatigue increases would not only have occurred after 24 hours but also earlier had the patient answered questions on fatigue in 12-hour or even shorter time intervals instead of 24-hour ones. In support of our findings, however, it could recently be found in healthy adults exposed to rhinovirus or influenza virus that daily production of IL-6, but not IL-1β or TNF-α, was associated with reduced concurrent daily positive affect, whereas daily production of IL-6, IL-1β, and TNF-α was related to lower positive affect on the next day (31) .
While in immunotherapy studies parenteral induction of fatigue occurs in all patients, is highly reproducible, stoppable after cessation of cytokine infusion and dose-related with lower doses of recombinant cytokine triggering sub-clinical increases in fatigue (10, 26, 27, 32, 33) , evidence relating cytokines to subclinical depressive symptoms is equivocal (34) . This inconsistency could be a consequence of the bidirectional nature of the relationship between mood and immune system (34) . It has recently been suggested that the rise in negative affect after parenteral administration of recombinant cytokines may not only be due to the pro-inflammatory cytokine activity per se but just as well to the stressful experience of cytokineinduced physical symptoms (31) . The current study analyzed the complex relationship between mood and cellular immune activity under real-life conditions and found that decreases in mood preceded neopterin level increases and not vice versa. Under real-life conditions, which are characterized by a complex interplay between diverse elements (35) -biological as well as psychosocial -, the link between stress and mood alteration and stress and changed immunity may be crucial in explaining the putative link between the immune system and mood alteration (36) . Indeed, the long temporal delay of 96 hours with which mood decreases preceded neopterin increases in the patient of this study suggests that decreases in her mood may have been parallelized by psychosocial stressors (37) .
We have recently tested stress system functioning in three patients with systemic lupus erythematosus (SLE) and in a healthy woman under real-life conditions and also found long time intervals between emotionally meaningful everyday stressors and changes in urinary cortisol and neopterin concentrations: in SLE, urinary cortisol levels decreased a total of 36 hours after the occurrence of stressors whereas urinary neopterin concentrations increased after a total of 48 to 60 hours following stressors (12, 13, 38) . Results from a study on a healthy woman mirrored these findings in that emotionally stressful incidents were followed by increases in urinary cortisol concentrations after a total of 72 hours and by urinary neopterin level decreases after a total of 24 hours (unpublished findings). These results support the suggestion of a hypoactive stress system in SLE, where stress is related to a blunted cortisol response and an increased (disinhibited) inflammatory activity (39) (40) (41) (42) (43) . The patient of the current study may also have a disturbed stress system, as decreases in mood were associated with increases and not with decreases in urinary neopterin levels as expected from normal stress system functioning (44) (45) (46) . In addition, as there is a continuum ranging from common normal feelings of sadness to pathological depression (14) , it can be hypothesized that if the patient of this study had pathologically enhanced depressive symptoms she also would show elevated neopterin concentrations and -as increases in her neopterin concentrations precede increases in fatiguewould suffer from CaRF. This study has several limitations which might have impaired the validity of findings: 1) The restrictions in data quality, i.e., the skewed fatigue time series and the single large deviations in both the neopterin and mood time series; 2) the short fatigue time series -in future research on this topic more data have to be considered; 3) the use of a 10-cm VAS scale to ask for fatigue instead of a more specific measure that includes multi-ple aspects of fatigue; 4) the use of neopterin as the only indicator of pro-inflammatory response and indirect marker of cytokine activity. Perhaps a more differentiated access to both fatigue and pro-inflammatory activity in a patient who suffers from CaRF, i.e., who indicates higher levels in daily fatigue than the patient of this study, would have revealed other cause-effect relations and temporal delays than those seen in the current investigation.
The findings of this study remain very preliminary, notably because they are based on only one case. Nevertheless, they provide new insights into the complex relationships between pro-inflammatory activity, mood and fatigue under real-life conditions. They indicate that some of the inconsistencies in current research on cancer-related sickness behavior, e.g., the equivocal evidence relating cytokines to sub-clinical depressive symptoms (34) , may be related to bidirectional effects and varying temporal delays among immunological and psychological variables. As the choice of appropriate antidepressive treatment (i.e., psychotherapy, pharmacotherapy) depends on knowledge on cause-effect relations between depression and physiological activity such as immune activity, approaches that permit a realistic description of the natural interrelationships among variables should be applied in future research on this topic.
